PIONEERING INNOVATION IN THE UPSTATE
Upstate South Carolina is home to premier industry and research partnerships that are making important breakthroughs each year. The region has a long-established history and infrastructure supporting all levels of the life sciences industry, with companies supplying high purity raw materials and components to production and packaging and distribution. New research and innovation campuses are supporting the growth of longstanding industry players, as well as fueling an ecosystem for start-ups.
Upstate South Carolina has a long-established history and infrastructure supporting all levels of the life sciences industry, from companies supplying high purity raw materials and components to production and packaging and distribution. World-class entities feed this supply chain, which explains why the Upstate was recognized as one of six emerging medium-sized regions for the industry.
South Carolina boasts significant business activity within the medical device sector and a particularly robust medical device manufacturing supply chain. From 2015-2019, companies in medical devices and equipment added 35% more jobs and 11.5% more companies in South Carolina.
Research & Development
The Upstate has a strong network supporting clinical research as well as a growing patient catchment area. It is home to a variety of incubation spaces and over 700 clinical trials are being conducted at any time in a variety of disciplines.
Major areas of focus: oncology, companion diagnostics, genetics and medical devices.
Upstate South Carolina has an established base of pharmaceutical manufacturers comprised of bulk manufacturers, chemical processors, generic and proprietary drug makers and packagers.
SCBIO supports and advances South Carolina’s life science industry through collaboration, advocacy, workforce development, enhanced purchasing power and education. The organization works towards ensuring that South Carolina’s companies, research institutions, and citizens reap the economic and societal benefits of a world-class life sciences cluster.
CUBEInC is a 30,000 square foot research facility located on the Prisma Health’s Patewood campus, focusing on developing high-impact medical technology and devices for disease management. At CUBEInC, Clemson faculty and students work closely with researchers from Prisma Health and the Steadman Hawkins Clinic of the Carolinas in the fields of biomaterials and devices.
The 191-acre campus is equipped with some of the best data infrastructure in the state and is home to over 180 medical professionals, along with the Clemson University Center for Human Genetics and the Greenwood Genetics Center. It is a dynamic knowledge community for collaboration, providing a deeper research base, a critical mass of scientists and capabilities, and the ability to provide advanced education and training in genetics and life sciences.
The Upstate has a network of excellent hospitals, technical training schools and more than 26 colleges and universities actively working together with industry leaders and educators on all levels, from K-12 to technical training and professional advancement, to ensure access a highly-skilled workforce for decades to come.
Upstate South Carolina is home to four technical colleges focused on serving the needs of local business and industry. The technical college system works hand-in-hand with its affiliate programs: readySC™, Apprenticeship Carolina™ and QuickJobs Carolina™, so companies located in the area can take full advantage of the extensive education and training network.South Carolina has a strong workforce development system. With these resource, the Upstate capable of rapidly preparing and retraining workers for new manufacturing systems, such as those potentially required by bio-related operations.
Clemson University is working under a new paradigm for integrated applied research in medical curricula. The University has put a priority of targeted and competitive recruitment of faculty, staff and students, and constructed a unique environment for enhanced visibility and reputation within the industry. The outcomes not only include enhanced patient care and healthcare delivery, but also stimulated economic development and a clear competitive advantage in the medical and biomedical engineering education market place.
Genetics & Biochemistry
Chemical & Biomolecular Engineering
Upstate Graduate Programs
- Clemson University Graduate School
- The Edward Via College of Osteopathic Medicine, Carolinas Campus
- Presbyterian College School of Pharmacy
- Prisma Health–Upstate/University of South Carolina School of Medicine Greenville
- University of South Carolina Graduate School
- Spartanburg Regional Healthcare System, Department of Medical Education
- Medical University of South Carolina College of Graduate Studies
- Greenwood Genetics Center Postdoctoral Genetics Training Program
Intellectual Property and Contract Law Professionals
The Upstate provides a rich environment of legal support, with over 100 attorneys and agents with licenses to practice before the US Patent & Trademark Office. As your connection to the Upstate Biosciences industry, we can connect you with these support providers.
Start-Up Grants & Seed Funding
SC Launch! offers qualifying companies commercialization support and guidance, and up to $200K in seed funding. Since its inception in 2006, SCLaunch! has invested over $49.6 million to 180 entities. Forbes named SCLaunch! a TOP 5 program for entrepreneurs!
UCAN – Upstate Carolina Angel Network
UCAN is a group of accredited investors located in the Upstate who invest in and support start-up and early-stage, high growth businesses in the Southeastern US. Since its inception in 2008, UCAN has invested more than $5.6 million in 22 companies.
Other funding programs:
South Carolina offers several programs designed to incent the location and expansion of biomedical companies and venture investment within the state including:
- An eligibility category for relevant facilities engaged in manufacturing, processing and R&D (NAICS codes 3254 and 334516)
- An enhanced Jobs Development Credit, which allows approved bioscience facilities to capture cash rebates for eligible expenditures
- The ability to negotiate the apportionment formula used to calculate corporate income tax liability
- Equipment depreciations at an accelerated rate of 20%, instead of the previous 11%